2026-04-30
SHANGHAI, March 13, 2026 — China's National Medical Products Administration (NMPA) has granted market approval for the world's first invasive brain-computer interface (BCI) Class III medical device, a landmark milestone that moves the transformative neurotechnology from laboratory research to standardized large-scale clinical use globally.
